The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
10/03/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
W81XWH-12-CRMRP-RTR
Opportunity Category:
Discretionary
Posted Date:
Oct 03, 2012
Creation Date:
Oct 03, 2012
Original Closing Date for Applications:
Dec 05, 2012
Current Closing Date for Applications:
Dec 05, 2012
Archive Date:
Jan 04, 2013
Funding Instrument Type:
Cooperative Agreement
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
1
Estimated Total Program Funding:
$13,750,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The Assistant Secretary of Defense for Health Affairs, Defense Health Program Research and Development Office is soliciting applications for the Fiscal Year 2012 (FY12) Restorative Transplantation Research (RTR) Program. The RTR program focus is funding innovative projects that have the potential to make a significant impact on improving the function, wellness, and overall quality of life for injured military Service members and veterans, their caregivers and family members, and the American public.
The FY12 RTR program challenges the scientific community to design innovative research that will foster new directions for and address neglected issues in the field of RTR-focused research. Applications from investigators within the military Services, and applications involving multidisciplinary collaborations among academia, industry, the military Services, the Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged. Though the RTR program supports groundbreaking research, all projects must demonstrate solid scientific rationale.
RTR, also known as reconstructive composite tissue allotransplantation or vascularized composite allotransplantation, is a maturing field. This laboratory research program will give special consideration to projects aimed at modifying or restructuring clinical practice guidelines and to projects intended to bring research findings rapidly into RTR clinical practice. The investigator(s) are encouraged to consider approaches utilized in solid organ transplantation for standardization of processes and protocols.
The intent of the FY12 RTR program is to promote multi-institutional, multidisciplinary partnerships among clinicians and basic scientists that accelerate the movement of promising ideas in reconstructive composite tissue transplantation into clinical applications. The Cooperative Agreement is intended to support both new and established scientists across a broad spectrum of disciplines in research projects that are likely to have a major impact on reconstructive composite tissue allotransplantation research. Leveraging already funded restorative transplantation (RT) procedures in order to investigate other aspects of the RTR knowledge base is encouraged. Applicants are also encouraged to demonstrate a portfolio of research projects representing a range of development stages.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
